highest qualiti beat one
discount name
ci report clean solid guidanc
ci ralli thursday compani report clean beat
estim ep revenu medic loss ratio script show
pharmaci earn growth reaffirm guidanc despit increment drag
health insur fee hif note clean q/mlr beat contrast
messi quarter gener report peer make current valuat discount
even surpris lower estim new hif impact
time issu reaffirm estim roll estim
overal ci appear track exceed target better expect
core growth capit deploy reiter buy
apples-to-appl pbm growth hard discount
signific skeptic around growth outlook pharmaci benefit
manag pbm busi ci close segment see core growth y/i
pre-tax earn within target rang laid deal close addit ci
expect hit script growth target year earli see nearli growth
segment next year ci report strong pbm result throughout
becom harder investor discount growth earn busi
help compani narrow gap peer
fischbeck focu pars guidanc
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu pars detail guidanc
guidanc came in-lin better expect core busi line
select/middl market medicar advantag pbm intern track
strong growth although guidanc alreadi lay compel growth stori
signific potenti addit upsid organ growth synergi capit
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag
organ pharmaci benefit manag
us compani also offer global
supplement benefit disabl life
esrx deal add capabl cash-flow
potenti ep upsid think ci could
achiev close low end pro forma
ep target year earli
compel aspect deal
gener much pf parent
combin
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu pars detail guidanc
guidanc came in-lin better expect core busi line
select/middl market medicar advantag pbm intern track
strong growth although guidanc alreadi lay compel growth stori
signific potenti addit upsid organ growth synergi capit
busi track ahead lt target
earn ci broke detail expect across key
segment consolid entiti break impli outlook
rest segment specif broken guidanc well illustr
adjust
guidanc call pbm health plan segment oper incom essenti
match full consolid oper earn guidanc impli
 segment earn net corpor segment
use interest expens guidanc slight growth corpor load
low-end lt intern earn growth target potenti drag coronaviru
impli segment grow
ci talk y/i earn trajectori exclud baselin
pre-tax health plan segment hif also adjust
after-tax consolid earn one-tim tax item make
adjust all-in pbm adjust need health plan consolid
enterpris expect grow well midpoint lt target guidanc
addit upsid capit deploy
tabl busi either track ahead lt target
bridg compani guidanc impli earn growth segment
commerci membership gain driven select/middl
earlier year investor confer ci gave preliminari high-level membership
guidanc street expect today ci gave detail guidanc explain lot
delta ci expect lose member non-cor govern
segment off-set higher expect growth continu growth
commerci employ busi ci break contribut
commerci risk/administr servic aso give high level commentari
around sub-seg ci talk nation account mostli aso flat
meanwhil middl market busi see solid growth mostli aso risk
nation select fastest grow risk addit partnership
oscar bring ci back grow small group segment like risk though
expect modest gain year taken togeth expect major commerci
membership growth come risk slight gain aso book given
higher revenu associ risk vs aso commerci revenu growth well
membership growth meanwhil note smaller aso custom segment
gener revenu associ nation account given
tend bundl product vision dental stop loss etc allow
compani drive profit growth even net membership growth somewhat modest
lose low revenu nation account replac higher revenue/margin select
tabl commerci risk like continu outpac aso growth despit return hif
bridg compani guidanc membership growth
pbm segment pivot strong growth lt target
highlight earlier ci expect pbm segment grow midpoint
well lt target illustr compar earn number
highlight growth legaci esrx year despit transit follow
stronger expect guidanc ci mention pbm busi see
mid-singl digit msd growth y/i conserv assum
appli regular season ramp notabl earn per script declin
y/i bring lower margin core ci prime busi prime
also includ servic eg exclud specialti lower ebitda per script ci
report strong pbm result throughout becom harder investor
discount result apples-appl without distort adjust
tabl pbm segment continu ramp earn script
bridg compani guidanc y/i pbm profit
ci bridg core earn
conclus busi track ahead schedul
guidanc came in-lin better expect core busi
line show adjust growth lt guid addit ci report strong
pbm result throughout would becom harder investor discount
result apples-appl although guidanc alreadi lay compel growth
stori signific potenti addit upsid organ growth
synergi capit deploy reiter buy
ci provid initi adjust ep guidanc
midpoint come consensu explain part unexpect impact
hif repeal vs prior guid fact guidanc assum capit
deploy consensu includ estim repres growth
mid adjust prior period develop return hif one-
time tax item call oper earn growth slightli compani
ci expect ep due season split
less consist prior year addit compani longer exclud
contribut transit client transit mostli complet
compani guid consolid adj oper incom
pre-tax op incom integr medic busi
pre-tax op incom servic busi expect growth
integr medic driven administr synergi effect cost
manag strong membership growth core select/middl market segment
expect organ growth medicar advantag consum
ci forecast pre-tax oper incom grow health servic
busi adjust pharmaci claim still expect
compani guid earli januari well ahead initi target script
given investor day
see full year medic loss ratio ci guid
repres decreas y/i seem fit ci note
higher due mix individu medic busi compani
also expect cost trend remain stabl guid rang
see cost trend ci seem impact potenti
higher util among member compar manag care organ
mco quarter
oper cash flow ci plan realiz least cffo see
figur grow notabl compani top capit deploy
prioriti remain lower debt-to-capit ratio current debt-to-
cap ratio ci hope short-term focu acceler debt pay achiev
ratio end lastli compani reiter commit
achiev ep target
adjust incom
adjust pre-tax incom op
oper
po base ep estim stock five-year averag pe
ratio feel conserv multipl reflect regulatori uncertainti
risk po deal integr risk issu disabl life busi
compani see higher expect cost trend potenti impact futur
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
